HNGE Hinge Health, Inc.
XNYS
119.36
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
What changed
Recent filings, trades and moves- 52-Week Range
- $30.08 – $124.94
- YTD
- +161.98%
- IV Rank (30D)
- 27.83
- Straddle Price
- $17.00
- P/C Vol Ratio
- 0.63
- Market Cap
- $9.3B
- Open
- $116.22
- Day Range
- $116.01 – $119.85
- Volume
- 599,767
- Prev Close
- $115.76
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 1.37 |
| Cost of Equity (CAPM) | 12.41% (VRP-adj) |
| WACC | 12.66% |
| Volatility Risk Premium | +50.1pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 1.7% |
| Rev. Growth (YoY, DCF input) | +30.0% |
| DCF Horizon | 15 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.3B |
| Return on Equity (TTM) | 31.2% |
| Book / Price | 3.6% |
| Gross Margin (TTM) | 84.5% |
| FCF Margin (TTM) | 39.9% |
| Debt / Equity | 0.00 |
| Quality Score | 6/6 — compounder (15y DCF) |
| Market-Implied Growth | +20.7% (reverse-DCF on current price) |
| SMA 50 | $100.83 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $111.05 |
| Bollinger Width / SMA20 | 20.1% (drives anchor stability) |
| Net Debt | $-0.3B |
| Market Cap | $10B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $211.71 | 21% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $51.49 | 9% | median 36.4× · 5 peers |
| Peer EV/EBITDA | $36.77 | 9% | median 25.7× · 5 peers |
| Peer P/B | $42.76 | 2% | median 10.4× · 6 peers |
| Peer P/S | $111.51 | 6% | median 11.7× · 6 peers |
| Market Anchor (SMA50) | $100.83 | 32% | stability 75% (BB-width) |
| Options Expected (B-L 30d) | $116.18 | 20% | 19 strikes · skew +0.06 |
- Industry (SIC)
- SERVICES-COMPUTER PROCESSING & DATA PREPARATION (7374) · industry map
- Exchange
- XNYS
- Market Cap
- $9.3B
- Employees
- 1,437
- List Date
- 2025-05-22
- CIK
- 0001673743
- Last Earnings
- Nov 2 after close · +1.2% vs ±14.8% expected
- Next Earnings
- ~Feb 9, 2027 (estimated)
- Headquarters
- San Francisco, CA
- Homepage
- https://www.hingehealth.com
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '25 | '26 | Avg |
|---|---|---|---|
| Jan | -- | -23.40% | -23.40% |
| Feb | -- | 21.37% | 21.37% |
| Mar | -- | -14.04% | -14.04% |
| Apr | -- | 15.87% | 15.87% |
| May | 3.41% | 23.73% | 13.57% |
| Jun | 27.94% | 36.24% | 32.09% |
| Jul | -0.79% | -11.91% | -6.35% |
| Aug | 24.76% | 19.20% | 21.98% |
| Sep | -11.85% | 8.02% | -1.92% |
| Oct | 2.07% | 16.72% | 9.39% |
| Nov | -2.84% | 3.49%* | 0.33% |
| Dec | -3.15% | -- | -3.15% |
| Total | 38.65% | 113.86% | 76.26% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall Assessment: BULLISH (Confidence Level: 8/10)
Key Drivers:
- Strong technical momentum, with a bullish MACD signal
- Overbought RSI indicating potential short-term correction
- Positive news sentiment driving the stock price upward
Primary Risks:
- High volatility, as evidenced by beta of 1.29 and historical volatility levels
- Potential for overbought condition to lead to short-term correction
Investment Thesis: HNGE is a high-growth healthcare stock with strong technical momentum and positive fundamental drivers. The company's recent news headlines have been overwhelmingly positive, contributing to the stock's upward price movement.
Recent News Sentiment Impact: The positive news sentiment has driven the stock price upward, with 5 out of 6 recent news articles exhibiting a positive tone. This is likely to continue supporting the stock's price movement in the short-term.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Bullish
- Medium-term (1-3 months): Bullish
- Long-term (3-12 months): Bullish
Support/Resistance Levels:
- Upper Bollinger Band: $76.76
- Middle Bollinger Band: $65.76
- Lower Bollinger Band: $54.76
Momentum Signals:
- RSI: 84.43 (overbought)
- MACD signal: Bullish
- Bollinger Bands position: Overbought
Volume Analysis:
- Volume SMA 20: 2467373.20
- On-Balance Volume (OBV): 61328236.11
- Volume Rate of Change: 265.39%
News & Sentiment Analysis
Recent Headlines Summary: The recent news headlines have been overwhelmingly positive, with themes centered around digital health solutions and increasing investment in health and fitness apps.
Sentiment Assessment: The aggregate sentiment is positive, driven by the majority of recent news articles exhibiting a positive tone.
Catalyst Identification: No immediate catalysts are identified, but the upcoming earnings report could provide further insight into the company's financial performance.
Market Narrative: The positive news sentiment has driven the stock price upward, aligning with the technical signals. The market narrative is one of optimism and growth potential for HNGE.
Risk & Volatility Assessment
Risk Assessment:
- Beta: 1.29 (high risk)
- Volatility Regime: High volatility
- Options Market Signals:
- IV rank: 20.7% (low)
- Put/call ratio: 0.38 (bullish)
Downside Protection: The lower Bollinger Band provides support at $54.76, and the recent news headlines suggest that this level may hold.
Market Context & Positioning
Market Performance: HNGE is outperforming the broader market, with a relative strength index of 0.53.
Institutional Activity: The volume patterns suggest institutional interest in the stock, as evidenced by the high volume flow and open interest levels.
Correlation Analysis: The correlation coefficient indicates that HNGE is positively correlated with the broader market (R-squared: 0.25).
Relative Valuation: HNGE is positioned within a trading range, with the upper Bollinger Band providing resistance at $76.76.
Key Levels & Action Items
Critical Price Levels:
- Support: $65.76 (middle Bollinger Band)
- Resistance: $76.76 (upper Bollinger Band)
Breakout/Breakdown Levels: No immediate breakout/breakdown levels are identified, but the upper and lower Bollinger Bands provide potential resistance and support levels.
Time-Sensitive Catalysts: The upcoming earnings report could provide further insight into the company's financial performance and drive market movements.
Risk Management: A stop-loss level of $70.00 is recommended to manage risk, with a position sizing consideration of 2-3% of the overall portfolio.
Recommendation:
Based on the analysis above, I recommend maintaining a long position in HNGE, as the technical momentum and positive news sentiment continue to drive the stock price upward. However, traders should be cautious due to the high volatility levels and potential for overbought conditions to lead to short-term corrections. A stop-loss level of $70.00 is recommended to manage risk.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2025-08-05 | After-Close | 16.23% | 25.57% | 1.58x | Exceeded |
| 2025-11-04 | After-Close | 21.24% | 15.06% | 0.71x | Within |
| 2026-02-10 | After-Close | 16.41% | 17.28% | 1.05x | Exceeded |
| 2026-05-05 | After-Close | 13.02% | 10.23% | 0.79x | Within |
| 2026-08-04 | After-Close | 12.78% | 1.73% | 0.14x | Within |
| 2026-11-02 | After-Close | 14.76% | 1.18% | 0.08x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
HNGE Options Activity & IV Rank
HNGE IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow · All expiries
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Estimated net dealer gamma is at the 90th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Above average volatility - stock moves with market amplification
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $63.0M | #262 of 3138 | +177.0% | 13F | |
| Citadel Hedge fund Ken Griffin | $62.9M | #576 of 6285 | -30.0% | 13F | |
| Point72 Hedge fund Steve Cohen | $22.3M | #559 of 1945 | -22.5% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $16.2M | #1260 of 3716 | -77.9% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $359K | #2261 of 4729 | +204.7% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
HNGE Institutional Ownership (13F)
Filings for 2026-06-30 · 131 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $52.30M | 33.18% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $33.16M | 21.04% | 2026-06-30 |
| 3 | GROUP ONE TRADING LLC Custodian | $19.57M | 12.42% | 2026-06-30 |
| 4 | PEAK6 LLC | $17.76M | 11.27% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $12.87M | 8.17% | 2026-09-30 |
| 6 | Citadel Advisors LLC Custodian | $11.60M | 7.36% | 2026-06-30 |
| 7 | Point72 Asset Management, L.P. | $5.59M | 3.54% | 2026-06-30 |
| 8 | Twin Tree Management, LP | $2.65M | 1.68% | 2026-06-30 |
| 9 | Simplex Trading, LLC Custodian | $1.74M | 1.10% | 2026-09-30 |
| 10 | TUDOR INVESTMENT CORP ET AL | $298.80K | 0.19% | 2026-06-30 |
| 11 | Concurrent Investment Advisors, LLC | $97.24K | 0.06% | 2026-09-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $20.94M | 35.79% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $15.21M | 26.00% | 2026-06-30 |
| 3 | IMC-Chicago, LLC Custodian | $9.80M | 16.75% | 2026-09-30 |
| 4 | Jane Street Group, LLC Custodian | $5.68M | 9.70% | 2026-06-30 |
| 5 | Squarepoint Ops LLC | $3.44M | 5.87% | 2026-06-30 |
| 6 | GROUP ONE TRADING LLC Custodian | $2.54M | 4.34% | 2026-06-30 |
| 7 | Simplex Trading, LLC Custodian | $748.75K | 1.28% | 2026-09-30 |
| 8 | Point72 Asset Management, L.P. | $149.40K | 0.26% | 2026-06-30 |
HNGE Insider Trading (Form 4)
Latest: 2026-11-06| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-06 | Elliott Robinson | Director | Sell (S) | — | — | EDGAR | |
| 2026-11-02 | James Budge | Chief Financial Officer | Tax (F) | −4,614 | $114.32 | -$527.5K | EDGAR |
| 2026-11-02 | James Pursley | President | Tax (F) | −831 | $114.32 | -$95.0K | EDGAR |
| 2026-10-13 | Gabriel M.I. Mecklenburg | Director | Mixed Sell −200,000 · Conv +200,000 |
— | $103.13 | -$20.63M | EDGAR |
| 2026-10-13 | James Budge | Chief Financial Officer | Sell (S) | −47,720 | $103.13 | -$4.92M | EDGAR |
| 2026-10-07 | Daniel Antonio Perez | CEO & Co-Founder | Mixed Sell −4,100 · Conv +4,100 |
— | $100.20 | -$410.8K | EDGAR |
| 2026-10-06 | Tyler Sloat | Director | Award (A) | +175 | $92.56 | $16.2K | EDGAR |
| 2026-10-01 | James Budge | Chief Financial Officer | Tax (F) | −4,614 | $97.24 | -$448.7K | EDGAR |
| 2026-10-01 | James Pursley | President | Tax (F) | −831 | $97.24 | -$80.8K | EDGAR |
| 2026-09-23 | James Pursley | President | Sell (S) | −33,000 | $94.14 | -$3.11M | EDGAR |
| 2026-09-16 | Elliott Robinson | Director | Sell (S) | — | — | EDGAR | |
| 2026-09-15 | Gabriel M.I. Mecklenburg | Director | Mixed Sell −150,000 · Conv +150,000 |
— | $93.22 | -$13.98M | EDGAR |
| 2026-09-14 | Gabriel M.I. Mecklenburg | Director | Mixed Sell −250,000 · Conv +250,000 |
— | $88.97 | -$22.24M | EDGAR |
| 2026-09-11 | Elliott Robinson | Director | Sell (S) | — | — | EDGAR | |
| 2026-09-11 | James Budge | Chief Financial Officer | Sell (S) | −55,561 | $89.45 | -$4.97M | EDGAR |
HNGE Insider Holdings
10 insiders · @ $119.44| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Bessemer Venture Partners X Institutional L.P. | 10%+ Owner | 3,383,707 | $404.15M | -$52.24M | 2 | 2025-11-20 |
| 2 | 11.2 Capital I, L.P. | 10%+ Owner | 1,396,340 | $166.78M | -$44.68M | 1 | 2025-05-27 |
| 3 | James Pursley | President | 665,247 | $79.46M | -$11.79M | 23 | 2026-11-02 |
| 4 | James Budge | Chief Financial Officer | 292,114 | $34.89M | -$14.28M | 27 | 2026-11-02 |
| 5 | Insight Venture Associates X, L.P. | 10%+ Owner | 217,442 | $25.97M | -$48.34M | 2 | 2026-06-29 |
| 6 | Insight Holdings Group, LLC | 10%+ Owner | 81,796 | $9.77M | -$173.12M | 2 | 2026-06-29 |
| 7 | Daniel Antonio Perez | CEO & Co-Founder | 39,570 | $4.73M | -$53.56M | 11 | 2026-10-07 |
| 8 | Kristina M Leslie | Director | 30,387 | $3.63M | -$417.7K | 5 | 2026-08-21 |
| 9 | Tyler Sloat | Director | 10,385 | $1.24M | $0 | 4 | 2026-10-06 |
| 10 | Teddie Benjamin Wardi | Director | 4,637 | $553.8K | $0 | 1 | 2026-08-12 |
HNGE Board & Officers
As of SEC filings through Nov 6, 2026Directors 6
- Daniel Antonio Perez · since May 21, 2025
- Elliott Robinson · since May 21, 2025
- Gabriel M.I. Mecklenburg · since May 21, 2025
- Kristina M Leslie · since May 21, 2025
- Teddie Benjamin Wardi · since May 21, 2025
- Tyler Sloat · since Mar 16, 2026
Officers 3
- Daniel Antonio Perez · CEO & Co-Founder · since May 21, 2025
- James Pursley · President · since May 21, 2025
- James Budge · Chief Financial Officer · since May 21, 2025
10% owners 14
- 11.2 Capital HH, LLC (entity) · since May 21, 2025
- 11.2 Capital I Partners, LLC (entity) · since May 21, 2025
- 11.2 Capital I, L.P. (entity) · since May 21, 2025
- 11.2 Capital Ivy Partners, LLC (entity) · since May 21, 2025
- 11.2 Capital Ivy, LLC (entity) · since May 21, 2025
- Atomico Advisors IV, Ltd. (entity) · since May 21, 2025
- Atomico IV (Guernsey), L.P. (entity) · since May 21, 2025
- Atomico IV, L.P. (entity) · since May 21, 2025
- Bessemer Venture Partners X Institutional L.P. (entity) · since May 21, 2025
- Bessemer Venture Partners X L.P. (entity) · since May 21, 2025
- Daniel Antonio Perez · since May 21, 2025
- Deer X & Co. L.P. (entity) · since May 21, 2025
- Deer X & Co. Ltd. (entity) · since May 21, 2025
- Qian Zhuang · since May 21, 2025
Changes in the last 10 years (41)
| Jul 9, 2026 | Insight Venture Partners X, L.P. reported in an SEC filing no longer being a 10% owner |
| Jul 9, 2026 | Insight Venture Partners X (Co-Investors), L.P. reported in an SEC filing no longer being a 10% owner |
| Jul 9, 2026 | Insight Venture Partners (Delaware) X, L.P. reported in an SEC filing no longer being a 10% owner |
| Jul 9, 2026 | Insight Venture Partners (Cayman) X, L.P. reported in an SEC filing no longer being a 10% owner |
| Jul 9, 2026 | Insight Venture Associates X, Ltd. reported in an SEC filing no longer being a 10% owner |
| Jul 9, 2026 | Insight Venture Associates X, L.P. reported in an SEC filing no longer being a 10% owner |
| Jul 9, 2026 | Insight Holdings Group, LLC reported in an SEC filing no longer being a 10% owner |
| May 11, 2026 | Elliott Robinson no longer listed as a 10% owner in SEC filings |
| Mar 16, 2026 | Tyler Sloat became a director |
| Nov 20, 2025 | Elliott Robinson first listed as a 10% owner in an SEC filing |
| May 23, 2025 | Gabriel M.I. Mecklenburg no longer listed as a 10% owner in SEC filings |
| May 21, 2025 | Teddie Benjamin Wardi became a director |
| May 21, 2025 | Qian Zhuang became a 10% owner |
| May 21, 2025 | Kristina M Leslie became a director |
| May 21, 2025 | James Pursley became President |
| May 21, 2025 | James Budge became Chief Financial Officer |
| May 21, 2025 | Insight Venture Partners X, L.P. became a 10% owner |
| May 21, 2025 | Insight Venture Partners X (Co-Investors), L.P. became a 10% owner |
| May 21, 2025 | Insight Venture Partners (Delaware) X, L.P. became a 10% owner |
| May 21, 2025 | Insight Venture Partners (Cayman) X, L.P. became a 10% owner |
| May 21, 2025 | Insight Venture Associates X, Ltd. became a 10% owner |
| May 21, 2025 | Insight Venture Associates X, L.P. became a 10% owner |
| May 21, 2025 | Insight Holdings Group, LLC became a 10% owner |
| May 21, 2025 | Gabriel M.I. Mecklenburg became a director |
| May 21, 2025 | Gabriel M.I. Mecklenburg became a 10% owner |
| May 21, 2025 | Elliott Robinson became a director |
| May 21, 2025 | Deer X & Co. Ltd. became a 10% owner |
| May 21, 2025 | Deer X & Co. L.P. became a 10% owner |
| May 21, 2025 | Daniel Antonio Perez became a director |
| May 21, 2025 | Daniel Antonio Perez became a 10% owner |
| May 21, 2025 | Daniel Antonio Perez became CEO & Co-Founder |
| May 21, 2025 | Bessemer Venture Partners X L.P. became a 10% owner |
| May 21, 2025 | Bessemer Venture Partners X Institutional L.P. became a 10% owner |
| May 21, 2025 | Atomico IV, L.P. became a 10% owner |
| May 21, 2025 | Atomico IV (Guernsey), L.P. became a 10% owner |
| May 21, 2025 | Atomico Advisors IV, Ltd. became a 10% owner |
| May 21, 2025 | 11.2 Capital Ivy, LLC became a 10% owner |
| May 21, 2025 | 11.2 Capital Ivy Partners, LLC became a 10% owner |
| May 21, 2025 | 11.2 Capital I, L.P. became a 10% owner |
| May 21, 2025 | 11.2 Capital I Partners, LLC became a 10% owner |
| May 21, 2025 | 11.2 Capital HH, LLC became a 10% owner |
- Prev
- 1
HNGE Proposed Insider Sales (Form 144)
Latest: 2026-10-14What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-10-14 | Insight Venture Partners X (Co-Investors), L.P. | 10% Stockholder | 17,825 | $1.87M | 2026-10-14 | Raymond James & Associates Inc | 10b5-1 | EDGAR |
| 2026-10-14 | Insight Venture Partners (Delaware) X, L.P. | 10% Stockholder | 118,822 | $12.48M | 2026-10-14 | Raymond James & Associates Inc | 10b5-1 | EDGAR |
| 2026-10-14 | Insight Venture Partners X, L.P. | 10% Stockholder | 749,091 | $78.65M | 2026-10-14 | Raymond James & Associates Inc | 10b5-1 | EDGAR |
| 2026-10-14 | Insight Venture Partners (Cayman) X, L.P. | 10% Stockholder | 614,262 | $64.50M | 2026-10-14 | Raymond James & Associates Inc | 10b5-1 | EDGAR |
| 2026-10-13 | GABRIEL MECKLENBURG | Director, Exec. Chairman & Co-Founder | 200,000 | $20.58M | 2026-10-12 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-10-13 | JAMES BUDGE | Officer | 47,720 | $4.91M | 2026-10-12 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-10-06 | DANIEL PEREZ | Director, Officer, 10% Stockholder | 4,100 | $403.2K | 2026-10-06 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-09-30 | Insight Venture Partners X (Co-Investors), L.P. | 10% Stockholder | 11,587 | $1.14M | 2026-09-30 | Raymond James & Associates Inc. | 10b5-1 | EDGAR |
| 2026-09-30 | Insight Venture Partners (Delaware) X, L.P. | 10% Stockholder | 77,248 | $7.57M | 2026-09-30 | Raymond James & Associates Inc. | 10b5-1 | EDGAR |
| 2026-09-30 | Insight Venture Partners X, L.P. | 10% Stockholder | 486,991 | $47.73M | 2026-09-30 | Raymond James & Associates Inc. | 10b5-1 | EDGAR |
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-02 | Earnings results · Director or officer change · Regulation FD disclosure | EDGAR |
| 2026-08-21 | Material agreement · New debt obligation | EDGAR |
| 2026-08-04 | Earnings results · Regulation FD disclosure · Other events | EDGAR |
| 2026-06-09 | Regulation FD disclosure | EDGAR |
| 2026-06-04 | Shareholder vote results | EDGAR |
| Filing Date | Accession | Link |
|---|
| Filing Date | Accession | Link |
|---|---|---|
| 2026-08-06 | 0001628280-26-054327 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $173.9M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.18% | $133.8M | $76.6B | 2026-11-06 |
| 3 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.07% | $123.0M | — | 2026-09-30 |
| 4 | VXF Vanguard Extended Market ETF | Vanguard | 0.07% | $65.0M | — | 2026-09-30 |
| 5 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.36% | $48.7M | $13.7B | 2026-11-06 |
| 6 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.06% | $40.0M | — | 2026-09-30 |
| 7 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.08% | $34.3M | — | 2026-09-30 |
| 8 | FESM Fidelity Enhanced Small Cap Core ETF | Fidelity | 0.41% | $27.1M | $6.6B | 2026-11-05 |
| 9 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.14% | $25.2M | — | 2026-09-30 |
| 10 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.06% | $18.7M | — | 2026-11-05 |
| 11 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.06% | $13.9M | — | 2026-08-31 |
| 12 | VHT Vanguard Health Care ETF | Vanguard | 0.06% | $13.1M | — | 2026-09-30 |
| 13 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 0.85% | $13.0M | $1.5B | 2026-11-06 |
| 14 | FPX First Trust US Equity Opportunities ETF | First Trust | 0.92% | $11.8M | $1.3B | 2026-11-06 |
| 15 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.01% | $11.2M | — | 2026-11-05 |
| 16 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.01% | $8.9M | $93.2B | 2026-11-06 |
| 17 | FMDE Fidelity Enhanced Mid Cap Core ETF | Fidelity | 0.10% | $8.5M | $8.6B | 2026-11-05 |
| 18 | FELC Fidelity Enhanced Large Cap Core ETF | Fidelity | 0.08% | $7.0M | $8.7B | 2026-11-05 |
| 19 | FNX First Trust Mid Cap Core AlphaDEX® Fund | First Trust | 0.43% | $6.0M | $1.4B | 2026-11-06 |
| 20 | FELG Fidelity Enhanced Large Cap Growth ETF | Fidelity | 0.11% | $5.6M | $5.1B | 2026-11-05 |
| 21 | KOMP State Street® SPDR® S&P Kensho New Economies Composite ETF | SPDR (State Street) | 0.22% | $5.1M | $2.3B | 2026-11-05 |
| 22 | SMLF iShares U.S. Small-Cap Equity Factor ETF | iShares (BlackRock) | 0.12% | $5.0M | $4.2B | 2026-11-06 |
| 23 | XHS State Street® SPDR® S&P® Health Care Services ETF | SPDR (State Street) | 2.05% | $5.0M | $242.8M | 2026-11-05 |
| 24 | TMAT Main Thematic Innovation ETF | Nport | 2.09% | $5.0M | — | 2026-07-31 |
| 25 | FNY First Trust Mid Cap Growth AlphaDEX® Fund | First Trust | 0.91% | $4.9M | $535.3M | 2026-11-06 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (5 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $212.82M | $43.10M | $0.52 | $101.41M |
| Q1 '26 | 2026-03-31 | $182.31M | $34.01M | $0.41 | $43.08M |
| Q4 '25 | 2025-12-31 | $170.73M | $32.09M | $2.11 | $63.89M |
| Q3 '25 | 2025-09-30 | $154.21M | $-1.84M | $-0.02 | $82.40M |
| Q2 '25 | 2025-06-30 | $139.10M | $-575.65M | $-13.10 | $20.23M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
HNGE vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| NVDA Nvidia Corp | $4.51T | 22.2 | +83.4% | −6.8% | 87 |
| TSM Taiwan Semiconductor Manufacturing Compa | $1.95T | — | — | +21.8% | 43 |
| SPCX Space Exploration Technologies Corp. Cla | $1.82T | — | — | −12.1% | 18 |
| AVGO Broadcom Inc. Common Stock | $1.40T | 40.7 | +48.7% | −8.3% | 81 |
| VEEV Veeva Systems Inc. | $49.2B | 50.2 | +16.5% | +39.7% | 81 |
| TEM Tempus AI, Inc. Class A Common Stock | $13.9B | — | +36.6% | +35.3% | 72 |
| HNGE Hinge Health, Inc. | $9.3B | 39.5 | +49.8% | +162.2% | 28 |
| DOCS Doximity, Inc. | $5.8B | 45.4 | +6.5% | −24.5% | 3 |
| WAY Waystar Holding Corp. Common Stock | $5.5B | 42.1 | +21.4% | −7.5% | 2 |
| Peer median | $725.6B | 42.1 | +29.0% | −7.1% | 58 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.